Tom Feegel is the Founder and CEO of Beond.  Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.  

In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction.  Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.    

https://www.beond.us   

Mycrodose's CEO Chad Conner and CSO Frank Kochinke return to the podcast to tell us about:   

⭐️  Follow Mycrodose:  https://mycrodosethera.com/ 

🔥. Follow Brom:  https://www.twitter.com/therealbrom 

⏰  Timestamps:  

Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.  

Mindstate's mission is to map the biological basis of the varieties of psychedelic experience, and to use that map to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders.  Mindstate participated in Y Combinator in 2021.   

Check out Mindstate @ https://www.mindstate.design/

Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approach to patient health, leveraging ketamine and the integration of tech.  

Check out Nue.Life here:  https://nue.life/   

⏰  Timestamps:  

0:00 intro and Juan Pablo’s backstory 

5:30 how Nue Life got started  

11:00 the Nue Life patient experience   

20:40 the intersection of data and mental health 

32:30 competition in the Ketamine landscape  

37:00 is ketamine addictive?  

45:00 the future of at-home ketamine and the Ryan Haight act 

49:15 legal psilocybin in Oregon? 

53:30 what’s next for Nue Life?

Eesmyal Santos-Brault & Dr. Pamela Kryskow from Quantified Citizen talk about Quantified Citizen the app, and the results of Quantified Citizen's first study:  Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.  

Check out the paper here:  https://www.nature.com/articles/s41598-021-01811-4

💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc

The Integration Conversation is BACK with Nadia van der Heyden, Director of Sales and Marketing at Psygen.  

Recorded at Wonderland Miami.     

💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc 

🐦 brom on twitter:  https://twitter.com/therealbrom 

💌 Email:   [email protected]

Brom discusses 10 interesting startup ideas for entrepreneurs in the psychedelics space.     

The ideas include applications of psychedelics to non mental health disorders, sexual disfunction, anti-aging, digital addiction, crypto, non-5ht2a drugs, gender specific issues, sustainable manufacturing and digital therapeutics.    

If you're an entrepreneur working on a psychedelic startup, we'd love to hear from you.  Please contact us at [email protected]   

💰 Invest in Brom's Psychedelic VC Fund: https://www.empath.vc 

📺 Watch on YouTube:  https://youtu.be/rpK8tzv2AaM

Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds.  In this episode of The Integration Conversation, Mycrodose's Chad Conner and Patrick Eckstrom join Brom to discuss how ADD systems can potentially improve the patient experience, increase the safety profile and lower the cost of psychedelic drugs.    

💰 Invest in Brom's Psychedelic VC Fund: 

https://www.empath.vc  

📺 Watch on YouTube:

https://youtu.be/HmBsrUQYyOg 

🐦 brom on twitter:  

https://twitter.com/therealbrom 

🎇 Clips and other stuff on Instagram:  

https://instagram.com/theintegrationco 

💌 Email:   

[email protected]

Richard Skaife is a cofounder of The Conscious Fund, one of the leading Venture Capital funds focused on psychedelic medicine, which has invested in companies like Cybin and Numinus Wellness.  Richard has a very eclectic background which includes producing electronic music events and being trained in the art of hypnotism.   Richard shares his views on the psychedelics industry, talks about what it's like to run a psychedelic VC fund, and announces Wonderland:  Miami - an in person psychedelics industry conference this November!     

❤️ Invest in Brom's Psychedelic Venture Fund: 

https://www.empath.vc

Todd Shapiro is the CEO of Red Light Holland ($TRIP, $TRUFF), the only publicly traded company focused on recreational psychedelics.    In this episode of The Integration Conversation, Todd explains the history of Red Light Holland, speculates on timelines for when Red Light Holland will be able to sell in the US, and tells us about Red Light Holland's foray into Virtual Reality and consumer products like the Wisdom Truffle.  

And of course, we ask the big question:  Is Red Light Holland Undervalued?   

---

❤️ Invest in Brom's Psychedelic Venture Capital Fund: 

https://www.empath.vc

📺Watch on YouTube:

https://youtu.be/1OzpNIQDkyI

⚠️Disclaimer: 

This content is not financial advice. Brom holds shares in Red Light Holland